Generic Sweden AB (GENI) AI Stock Analysis

• Market Cap: kr481.85M
• Dividend Yield: 3.48%
• Average Volume (3M): 20.09K
• Price to Earnings (P/E): 13.6
• Beta (1Y): 0.46
• Revenue Growth: 4.84%
• EPS Growth: 5.70%
• Country: SE
• Employees: 22
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 2.52
• Shares Outstanding: 12,292,020
• 10 Day Avg. Volume: 18,353
• 30 Day Avg. Volume: 20,086
• PEG Ratio: 1.31
• Price to Book (P/B): 8.56
• Price to Sales (P/S): 3.10
• P/FCF Ratio: 14.63
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 2.71
• Revenue Forecast (FY): kr196.00M

• Rating: 83 Outperform
• Price Target: kr48.00 ▲(3.34% Upside)
• Action: Reiterated
• Date: 05/14/26

Positive Factors

Debt-free balance sheet

Zero reported debt materially lowers financial risk and preserves strategic optionality. With equity rising to 66.6M (2025) from 22.0M (2020), the firm can fund organic growth, product investment, dividends or M&A without relying on external leverage, supporting durable financial resilience.

Negative Factors

Gross margin compression

Declining gross margins over several years suggest rising delivery costs or pricing pressure. Persisting gross margin erosion would reduce operating leverage and limit the ability to convert revenue growth into higher operating profits, forcing efficiency actions or price increases to sustain margins.

Generic Sweden AB Business Overview & Revenue Model

Company Description

Generic Sweden AB, a technology company, provides messaging services for all applications. It also offers a platform for digital communication services. The company was incorporated in 1993 and is headquareted in Stockholm, Sweden....

Generic Sweden AB Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	183.71M	176.45M	142.59M	127.73M	114.23M
Gross Profit	38.58M	44.72M	38.27M	35.54M	31.93M
EBITDA	39.58M	35.52M	30.16M	26.75M	24.16M
Net Income	31.04M	27.25M	23.31M	20.45M	18.13M
Balance Sheet
Total Assets	105.14M	88.97M	77.42M	68.04M	59.42M
Cash, Cash Equivalents and Short-Term Investments	58.24M	40.62M	37.20M	32.60M	31.07M
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Liabilities	38.55M	33.75M	31.01M	29.57M	29.11M
Stockholders Equity	66.59M	55.22M	46.41M	38.47M	30.31M
Cash Flow
Free Cash Flow	38.98M	21.85M	19.97M	13.82M	18.44M
Operating Cash Flow	39.73M	24.06M	21.84M	16.85M	19.89M
Investing Cash Flow	-2.44M	9.79M	-13.87M	-3.03M	-1.45M
Financing Cash Flow	-19.67M	-18.44M	-15.37M	-12.29M	-9.83M

Generic Sweden AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
GENI	83 Outperform	kr481.85M	13.64	―	3.48%	4.84%	5.70%
UPSALE	74 Outperform	kr501.78M	29.61	―	4.69%	9.15%	37.55%
CDMIL	65 Neutral	kr205.69M	32.22	―	3.25%	-27.56%	-99.50%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%